ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981

Centers Ask Americans for $1 Each for Research.

May 16, 2008

NIH Plans Grants For Those Who Barely Miss Payline

April 19, 1991

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011